Trial of OnabotulinumtoxinA for Depression in Parkinson Disease

NCT03069911 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Unable to recruit required participants

Conditions

Parkinson Disease
Depression

Interventions

BIOLOGICAL: OnabotulinumtoxinA
BIOLOGICAL: Control

Sponsor

Johns Hopkins University